Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artrosome C+D is a nutritional supplement developed and marketed by Laboratorio Arama, a Chilean subsidiary of OPKO Health. It is a combination product containing 10,000 mg of hydrolyzed collagen, Vitamin C (ascorbic acid), and Vitamin D (cholecalciferol) per sachet. Formulated as a powder for oral administration, it is intended to support joint nutrition and bone health. The hydrolyzed collagen provides essential peptides for cartilage and bone structure, while Vitamin C serves as a critical cofactor for collagen synthesis and Vitamin D facilitates the absorption of calcium and phosphorus. It is primarily indicated for the management of joint pain, osteoarthritis, and osteoporosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artrosome C+D.